Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - TOTAL DEBT REPAID
Total Debt Repaid ANAB - AnaptysBio, Inc.
-11.7 M
LAST VALUE
0.00%
2 YEAR CAGR
-11.27%
5 YEAR CAGR
-21.45%
10 YEAR CAGR